Like TGaS Advisors, LLC

closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

See 113 Comparable Transactions
synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
 target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/28/2022 via BusinessWire

AccessSync merged with Elandas, Inc.,

See 109 Comparable Transactions
synopsis: Elandas, Inc., a SaaS-based configurable technology solutions provider, announced it has merged with long-standing partner AccessSync, LLC, a US-based strategic market access execution services provider.
buyer: Elandas, Inc.
Elandas, Inc. is a SaaS-based configurable technology solutions provider. Combining automation and workflow, Elandas delivers operational excellence configured to each client’s specific business goals. They are based in Saint John, NB, Canada. "
 target: AccessSync
AccessSync delivers strategic market access planning and execution for biopharma companies seeking to accelerate growth in increasingly complex market access environments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2021 via Company Press Release

Sermo, acquired Minter Group

See 323 Comparable Transactions
synopsis: Sermo, the world’s leading healthcare provider insights company and the first social media platform for physicians, announced its acquisition of Australia-based market research leader, Minter Group. Since 2003 Minter has built a variety of research panels across various industries including IT, consumer and healthcare.
buyer: Sermo
Sermo is the world’s leading healthcare provider insights company and the first social media platform for physicians. They offer a unique physician-first online community that allows clinicians to communicate about issues that are important to them and their patients. "
 target: Minter Group
Minter Group is an Australia-based market research leader. Since 2003 Minter has built a variety of research panels across various industries including IT, consumer and healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/13/2021 via Company Press Release

Research America, Inc., acquired xsperient

See 51 Comparable Transactions
synopsis: Research America, Inc., the top marketing research firm located outside Philadelphia, has acquired xsperient, a prominent market research company in the field of applying the behavioral sciences to healthcare and wellness consulting, market research, and market segmentation.
buyer: Research America, Inc.
Research America is a full-service market research and consumer insights company. The company uses a consultative approach that leverages its diverse experience and innovative data-driven tools that produce results. "
 target: xsperient
xsperient is a full-service market research company using advanced techniques for qualitative and quantitative studies. They apply the measurable science of psychology and sophisticated mathematical modeling techniques to healthcare and wellness market research and market segmentation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2021 via GlobeNewswire

Cerner Corporation, acquired Kantar Health

See 77 Comparable Transactions
synopsis: Cerner Corporation, a global health care technology company, has acquired Kantar Health, a division of Kantar Group. Kantar Health is a leading data, analytics and real-world evidence and commercial research consultancy serving the life science industry.
buyer: Cerner Corporation (CERN:$5,707.53)
Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. "
 target parent: Bain Capital
target: Kantar Health
Kantar Health SA provides healthcare consulting and marketing research services. The company was formerly known as Taylor Nelson Sofres Healthcare SA. The company is based in Madrid, Spain. Kantar Health SA operates as a subsidiary of WPP plc.
price ($mm)
$375
rev ($mm)
$150
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

See 60 Comparable Transactions
synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
 target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/7/2020 via BNC Analysis

Integrated Medhealth Communication, acquired Porterhouse Medical Group

See 88 Comparable Transactions
synopsis: Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity. Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry.
buyer parent: Waterland Private Equity Investments
buyer: Integrated Medhealth Communication
Founded in 2006, Integrated Medhealth Communication (IMC) provides healthcare communication and medical affairs support to over 50 pharmaceutical, biotech, vaccine, device, and diagnostic companies globally, including eight of the 20 largest drug companies in the world. "
 target: Porterhouse Medical Group
Porterhouse Medical Group is a global strategic healthcare communications and insights research agency that provides scientific and medical expertise to the global pharmaceutical industry, with a focus on activities that have a beneficial and measurable impact on healthcare professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/4/2019 via BusinessWire

Pharmerit International merged with Open Health,

See 60 Comparable Transactions
synopsis: OPEN Health, a leading multi-disciplinary health communications and market access group, has merged with Pharmerit International, LP, the largest independent global provider of health economics and outcomes research and strategic market access services to the pharmaceutical industry.
buyer parent: Amulet Capital Partners LP
buyer: Open Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. "
 target: Pharmerit International
Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in HEOR and market access worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/25/2018 via Company Press Release

The WIRB-Copernicus Group, acquired KMR Group

See 7 Comparable Transactions
synopsis: WIRB-Copernicus Group (WCG), the leading provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired KMR Group, a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
 target: KMR Group
KMR Group is a global leader in the provision and analysis of benchmarking and other data for the biopharmaceutical industry. KMR offers leading-edge data, products, and services in the form of reports and on-line tools that inform client strategy and productivity as well as day-to-day operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

See 61 Comparable Transactions
synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
 seller: The Nielsen Company, Inc. (NLSN:$3,500.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2014 via Company Press Release

Cello Group, acquired Promedica, Inc

See 2 Comparable Transactions
synopsis: Cello Group plc, the healthcare and consumer strategic marketing group, is pleased to announce the acquisition of Worldwide Promedica Inc. Promedica is a San Francisco based market research firm serving pharmaceutical and biotechnology companies.
buyer: Cello Group (CLLL:$204.91)
Cello is a leading global insight and strategic marketing group with a primary focus on the pharmaceutical and health sectors in addition to deep expertise in a range of other high margin sectors. "
 target: Promedica, Inc
Promedica’s mission is to provide primary marketing research in the area of new product planning with an exclusive focus on healthcare, and a client-side perspective. Their ultimate goal is to optimize client's marketing research investment and contribute to company’s success.
price ($mm)
$0.70
rev ($mm)
$2
EBITDA ($mm)
EV / rev
1.3x
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

See 109 Comparable Transactions
synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
 target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2013 via BusinessWire

Audax Group, acquired Chesapeake Research Review

See 2 Comparable Transactions
synopsis: Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc. Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems.
buyer: Audax Group
Audax Group, founded in 1999, is a leading investor in lower-middle market companies. With offices in Boston and New York, Audax has over $5 billion in assets under management in its Private Equity, Mezzanine, and Senior Debt businesses. "
 target: Chesapeake Research Review
Chesapeake Research Review, Inc. provides human research protections services. It offers institutional review board services & human research protections consultation, including strategic & operational, IRB consultation services; ethical, scientific & applied bioethics review, education & auditing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

See 60 Comparable Transactions
synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
 target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/14/2012 via Market Wire

ImpactRx, Inc., acquired Source Healthcare Analytics, LLC

See 151 Comparable Transactions
synopsis: Symphony Technology Group announced that it has acquired Source Healthcare Analytics, LLC. STG will combine Source Healthcare Analytics with ImpactRx to form Symphony Health Solutions, which will be focused on delivering high-value data, analytics, and technology based solutions for clients across life science manufacturers, payers, and providers.
buyer parent: Symphony Technology Group
buyer: ImpactRx, Inc.
ImpactRx is the leading provider of consultative and analytically-based promotional effectiveness solutions to the healthcare industry. ImpactRx's ImpactData™ is the industry’s sole source of continuous-capture market promotion and physician treatment data. "
 target parent: Wolters Kluwer NV
target: Source Healthcare Analytics, LLC
Source Healthcare Analytics is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company's brands include Source®, ProMetis™ and inThought™.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

See 23 Comparable Transactions
synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
 target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

See 159 Comparable Transactions
synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
 target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

See 61 Comparable Transactions
synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
 seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2011 via BNC Analysis

Market Probe, acquired Richard Day Research Inc.

See 137 Comparable Transactions
synopsis: Market Probe has announced the acquisition of Richard Day Research Inc. (RDR), a specialist in financial services and pharmaceutical research based in Evanston, IL. RDR employs a range of methods from quantitative surveys of clients and prospects, to internal analyses of customer databases.
buyer: Market Probe
Market Probe is a global market research firm providing full-service strategic guidance and business solutions to major international companies. It specializes in customer satisfaction, employee and brand stakeholder marketing research, with in-house facilities for field services by Web and phone. "
 target: Richard Day Research Inc.
Richard Day Research Inc. is a specialist in financial services and pharmaceutical research based in Evanston, IL. Its specialties include advanced analytics, brand support, data collection, general public surveys, marketing effectiveness & win/loss, qualitative research, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/4/2011 via BNC Analysis

LA-SER Alpha Group Sarl, will acquire Analytica International, Inc.

See 23 Comparable Transactions
synopsis: Accentia Biopharmaceuticals, Inc. announced that it has entered into an agreement to sell the assets of its non-strategic business unit, Analytica International, Inc., a healthcare economics consulting firm to LA-SER, a London-based pharma research company.
buyer: LA-SER Alpha Group Sarl
LA-SER was founded in 2004, with a mission to bring cutting-edge scientific methodology to evaluate the real-world impact of medicines. Their goal is to find for whom and under which conditions of use the drugs will demonstrate best benefit to patients, with minimal harm. "
 target parent: Accentia Biopharmaceuticals, Inc.
target: Analytica International, Inc.
Analytica Group, Inc., a healthcare consultancy firm, provides pharmaceutical research and analysis solutions.
price ($mm)
$4.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

See 113 Comparable Transactions
synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
 target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2014 via Company Press Release

TGaS Advisors, LLC, acquired TGaS Advisors, LLC

See 109 Comparable Transactions
synopsis: TGaS® Advisors, the premier provider of benchmarking and advisory services to the commercial operations organizations of pharmaceutical and biotechnology companies, has been acquired by Trientis Vitae, a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. TGaS had been owned by ABRY Partners since 2010.
buyer parent: Geminin Investors, LLC
buyer: TGaS Advisors, LLC
Trientis Vitae is a newly-formed group led by TGaS founder Stephen Gerard and members of the senior management team. The buyout was sponsored by Gemini Investors which led a consortium of investors including Triangle Capital Corporation, Tregaron Capital Company and Salem Investment Partners. "
 target parent: ABRY Partners, LLC
target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2010 via Company Press Release

KnowledgePoint360 Group, LLC, acquired TGaS Advisors, LLC

See 109 Comparable Transactions
synopsis: KnowledgePoint360 Group, a global leader in communications and information services for healthcare professionals, has acquired TGaS Advisors, LLC, the premier provider of benchmark-based advisory services to the pharma and biotech industry.
buyer parent: ABRY Partners
buyer: KnowledgePoint360 Group, LLC
KnowledgPoint360 provides a broad range of medical communications services, including medical education, publication support, live educational meetings, scientific content development, exhibit design, digital solutions, training, workflow and compliance solutions. "
 target: TGaS Advisors, LLC
TGaS Advisors offers unique benchmarking and advisory services for clients in Sales Operations, Marketing Sciences & Operations, PDMA Compliance, Internet and Relationship Marketing, Training & Development, Commercial Compliance, and other key areas relevant to pharma and biotech companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/19/2022 via BusinessWire

Trinity Life Sciences, acquired D Cube Analytics

See 105 Comparable Transactions
synopsis: Trinity Life Sciences, a leader in global life sciences commercialization solutions, has acquired D Cube Analytics. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.
buyer parent: Parthenon Capital Partners
buyer: Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. "
 target: D Cube Analytics
D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/9/2020 via BusinessWire

Trinity Life Sciences, will acquire BluePrint Research Group

See 174 Comparable Transactions
synopsis: Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity as the premier partner for commercially focused strategy, insights and analytics for the life sciences industry and solidifies its global presence.
buyer parent: Parthenon Capital Partners
buyer: Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. "
 target: BluePrint Research Group
BluePrint Research Group consults with healthcare companies to inform global brand commercialization efforts for the industry’s most innovative therapies and products, impacting and improving global health and wellness.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/1/2019 via BusinessWire

Trinity, acquired Bell Canyon Consulting

See 32 Comparable Transactions
synopsis: TRINITY, the global life sciences commercialization solutions provider, has acquired Bell Canyon Consulting, a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services.
buyer parent: Parthenon Capital Partners
buyer: Trinity
TRINITY is a global commercialization partner to the life sciences industry, providing evidence-based solutions throughout the product lifecycle. TRINITY is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. "
 target: Bell Canyon Consulting
Bell Canyon Consulting is a data management consulting company with core expertise in master data management, data warehousing, business intelligence, and other information technology services. Bell Canyon’s mission is to enable life sciences clients to drive revenue.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

See 113 Comparable Transactions
synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
 target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/6/2018 via BusinessWire

Trinity Partners, acquired TGaS Advisors, LLC

See 113 Comparable Transactions
synopsis: Global life sciences consulting firm Trinity Partners announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
buyer parent: Parthenon Capital Partners
buyer: Trinity Partners
Trinity Partners provides state-of-the art approaches and solutions to the health care industry. They believe that accurate market assessments result from intensive data analysis and fact gathering. They believe that precise, targeted sales information gives clients a vital competitive edge. "
 target: TGaS Advisors, LLC
TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. TGaS provides robust comparative intelligence and collaborative network membership services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/9/2020 via BusinessWire

Trinity Life Sciences, will acquire BluePrint Research Group

See 174 Comparable Transactions
synopsis: Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity as the premier partner for commercially focused strategy, insights and analytics for the life sciences industry and solidifies its global presence.
buyer parent: Parthenon Capital Partners
buyer: Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. "
 target: BluePrint Research Group
BluePrint Research Group consults with healthcare companies to inform global brand commercialization efforts for the industry’s most innovative therapies and products, impacting and improving global health and wellness.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

See 174 Comparable Transactions
synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$855.69)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
 target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

See 60 Comparable Transactions
synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
 target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2019 via BusinessWire

Validant, acquired DataRevive LLC

See 38 Comparable Transactions
synopsis: Validant, a leading transatlantic quality, compliance and regulatory consulting group, has acquired DataRevive, a regulatory strategy and consultancy firm that focuses on supporting pharma and biotech to navigate the regulatory approval pathway for global clients in the US market.
buyer parent: GHO Capital
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
 target: DataRevive LLC
DataRevive is a leading Regulatory Affairs consulting firm, providing high quality advice and expertise from the perspective of industry and regulators to support customers from across pharma and biotech as they seek to navigate the regulatory approval process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

See 143 Comparable Transactions
synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
 target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

See 15 Comparable Transactions
synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
 target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/27/2021 via BNC Analysis

Paine Schwartz Partners, acquired Registrar Corp

See 20 Comparable Transactions
synopsis: Paine Schwartz Partners, a private equity firm specializing in sustainable food chain investing, has acquired Registrar Corp from Bertram Capital. Registrar, headquartered in Hampton, VA, is a provider of U.S. Food and Drug Administration compliance software and services to food, medical device, drug, and cosmetic facilities all over the world.
buyer: Paine Schwartz Partners
A global leader in sustainable food chain investing, Paine Schwartz Partners is a private equity firm focused exclusively on investment opportunities in the fast-growing, dynamic global food and agribusiness sectors. "
 target parent: Bertram Capital Management LLC
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities. Registrar Corp was founded in 2003 and has headquarters in Hampton, Virginia, USA.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

See 49 Comparable Transactions
synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
 target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

See 49 Comparable Transactions
synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
 target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

See 34 Comparable Transactions
synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
 target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

See 20 Comparable Transactions
synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
 target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

See 42 Comparable Transactions
synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
 target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

See 113 Comparable Transactions
synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
 seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

See 51 Comparable Transactions
synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
 target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2020 via BusinessWire

Accenture, acquired OpusLine

See 139 Comparable Transactions
synopsis: Accenture has acquired Paris-based OpusLine, one of the leading consulting companies that provides strategic advisory and transformational services to public- and private-sector healthcare providers as well as life sciences and insurance companies in France.
buyer: Accenture (ACN:$53,736.36)
Accenture is a global professional services company with leading capabilities in digital, cloud, and security. Accenture offers Strategy and Consulting, Interactive, Technology, and Operations services powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. "
 target: OpusLine
OpusLine is one of the leading consulting companies that provides strategic advisory and transformational services to public- and private-sector healthcare providers as well as life sciences and insurance companies in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/30/2020 via BusinessWire

Validant, acquired Idec Inc.

See 22 Comparable Transactions
synopsis: Validant, a leading transatlantic quality, compliance, and regulatory consulting group, has acquired IDEC, a leading regulatory consultancy in Japan. IDEC supports customers from across the globe and helps them navigate the Japanese market by providing strategic advice and hands-on implementation support.
buyer parent: GHO Capital
buyer: Validant
Validant is a leading international Quality, Compliance, and Regulatory consulting firm, blending industry expertise with innovation to create custom solutions for companies on the frontier of health. "
 target: Idec Inc.
IDEC is a leading regulatory consultancy in Japan for drug development solutions. The company offers its professional services as the “Virtual Japan Team" for its clients, focusing on providing high value-added R&D and market access services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

See 24 Comparable Transactions
synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
 target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

See 22 Comparable Transactions
synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
 target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

See 16 Comparable Transactions
synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
 target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

Like TGaS Advisors, LLC


read more

TGaS Advisors, LLC

AccessSync

Minter Group

xsperient

Kantar Health

Elysia Group

Porterhouse Medical Group

Pharmerit International

KMR Group

The Nielsen Company, Inc.

Promedica, Inc

TGaS Advisors, LLC

Chesapeake Research Review

Double Helix

Source Healthcare Analytics, LLC

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

Richard Day Research Inc.

Analytica International, Inc.

Pages:  
read more

TGaS Advisors, LLC

TGaS Advisors, LLC

TGaS Advisors, LLC

read more

D Cube Analytics

BluePrint Research Group

Bell Canyon Consulting

TGaS Advisors, LLC

read more

TGaS Advisors, LLC

BluePrint Research Group

The Frankel Group Associates LLC

CFS Clinical

DataRevive LLC

Tardis Medical Consultancy

Adjility Health

Registrar Corp

Kinetiq

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Mindlance

BioSoteria, Inc.

OpusLine

Idec Inc.

DT Associates

Putnam Associates

Tri Stat

Pages:  
Geography
Matching Companies
Ticker: ISE:UPR
 
 
 
 
 
 
 
 
Uniphar plc
Uniphar plc
Uniphar plc is a trusted global partner to pharma and medtech manufacturers, working to improve patient access to medicines in Europe and around the world. They provide outsourced and specialised services to clients.
year
2021
rev ($mm)
$2,171.45
EBITDA ($mm)
$69.73
EBIT ($mm)
$61.58
Net Income ($mm)
$34.52
Employees
3200
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PGND
 
 
 
 
 
 
 
 
Press Ganey Associates, Inc.
Press Ganey Associates, Inc.
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement.
year
2016
rev ($mm)
$344.32
EBITDA ($mm)
$104.94
EBIT ($mm)
$60.70
Net Income ($mm)
$27.26
Employees
1058
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ISE:UPR
 
 
 
 
 
 
 
 
Uniphar plc
Uniphar plc
Uniphar plc is a trusted global partner to pharma and medtech manufacturers, working to improve patient access to medicines in Europe and around the world. They provide outsourced and specialised services to clients.
year
2021
rev ($mm)
$2,171.45
EBITDA ($mm)
$69.73
EBIT ($mm)
$61.58
Net Income ($mm)
$34.52
Employees
3200
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch